Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-058025
Filing Date
2008-10-22
Accepted
2008-10-22 17:46:45
Documents
1
Period of Report
2008-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd221419.html 4  
1 FORM 4 rrd221419.xml 4 3459
  Complete submission text file 0001181431-08-058025.txt   5355
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address 650-244-4990
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 081135893